• Researchers Suggest Two Dietary Supplements To Prevent Breast Cancer

    Posted September 10, 2013: by Bill Sardi

    You can read the abstract of their report for yourself, as published in the Molecular Aspects Of Medicine journal, published online August 29, 2013.  University of Nebraska Medical Center researchers say estrogen imbalance promotes breast cancer.  DNA adducts are formed, which is a piece of DNA bonded to a cancer-causing chemical.

    These researchers say “the dietary supplements resveratrol and N-acetylcysteine (NAC) can act as cancer preventing agents by keeping estrogen metabolism balanced.”  These are inexpenstive and could prevent “many of the prevalent types of human cancer,” they say.

  • Immune-Boosting Vitamin Cure From Japan Goes Online

    Posted July 24, 2013: by Bill Sardi

    The Saisei Mirai Clinics in Kobe, Japan have taken their “cancer cure” online and graphically describe how it works, including published studies for the more scientific investigator.  A key part of the therapy is injection of Gc-macrophage activating factor (Gc-MAF) which is gleaned from blood samples of healthy adults.  Gc-MAF instructs white blood cells called macrophages to destroy cancerous cells as well as other foreign invaders like viruses.

    The Saisei Mirai Clinics report they have successfully treated 345 consecutive patients with terminal metastatic (spreading) cancer.  Some cases are reported at the website.  They include the case of a 62-year old woman who was diagnosed with uterine cancer with spreading to the lymph nodes in 2011 and had undergone two prior chemotherapy sessions.  After a battery of treatments to boost her own immune system, she achieved complete remission from cancer in 2013 (no tumor visible on CAT scan and normal tumor markers).

    Read the whole post »

  • Update II: Cancer Immunotherapy From Japan

    Posted July 14, 2013: by Bill Sardi

    Various skeptics challenged my online report of a study published in the journal Anticancer Research that 345 patients with end-stage spreading (metastatic) cancer at a clinic in Japan had been successfully treated with immunotherapy.  That published report presented three cases as examples.  Skeptics claimed only 3 of the 345 treated patients were successfully treated.

    I have received confirmation directly from the Saisei Mirai Clinic in Kobe, Japan, that these patients were successfully treated and are in 1-2 year remission following treatment with injectable Gc-MAF (macrophage activating factor), intravenous vitamin C and oral vitamin D plus lipoic acid.  The clinic doctors report few if any side effects, improved quality of life, increased appetite in end-stage patients and prolonged survival. The e-mail received from Japan can be read below.

    Read the whole post »


    Posted July 12, 2013: by Bill Sardi

    1. A paper, written by investigators at the Fred Hutchinson Cancer Research Center in Seattle, as published in the Journal of the National Cancer Institute, is a follow-up from a prior study published in 2011 that reached a similar conclusion. So it’s not news. (See No. 4 below) It is a confirming study.  It appears to have been times for release to coincide with other negative reports involving dietary supplements.

    2. The paper did not factor for other dietary supplements; maybe the non-aggressive cancers were vitamin supplement users. It is well established that omega-3 oils can promote or inhibit cancer based upon a variety of factors not considered in this narrow data analysis. A list of the carcinogenic and anti-carcinogenic properties of omega-3 oils were published in the American Journal of Clinical Nutrition.

    Read the whole post »

  • They Know Cancer Cures Are Coming And They Need A Committee To Stop Them

    Posted July 9, 2013: by Bill Sardi

    In the British newspaper The Telegraph, a writer there promotes legislation that is alleged to permit innovation in the war against cancer without penalizing physicians for stepping outside established norms.  Twill bet you the proposed law is simply bait for passage of a law that ensures no threat will come to the reigning cancer industry.

    Yet, in the words that were penned in The Telegraph, it was also admitted that existing law “obliges the doctor to follow the status quo, even though he/she knows it leads only to poor life-quality followed by death.”  The report goes on to say “the current law requires the deceased receive only the ‘standard procedure’ – the endless repetition of a failed experiment.”

    Read the whole post »

  • How To Access And Implement The New Cancer Immuno-Therapy From Japan

    Posted June 25, 2013: by Bill Sardi

    The incredible report that doctors in Japan have convincingly cured cancer (see report: IS CANCER BEING CURED RIGHT BEFORE OUR EYES? – Knowledge of Health) speaks loudly for the route by which you are reading this breakthrough.  You are not reading about this breakthrough from the American Cancer Society, nor the National Institutes of Health, nor from the American Society of Clinical Oncology, not even The World Health Organization.

    Nor has the National Institutes of Health hurried together a press conference on this matter to announce immediate research funding.  The FDA has not announced it will mobilize to fast-track this therapy.  Nor does the Wall Street crowd make mention of it (the pharmaceutical sector of the markets would crash if this development was to be featured on evening network TV news.)

    Someone has said there is more money in treating rather than curing cancer.   That is a fact.  The American Cancer Society says the tab for cancer care in the world is more than $753 billion annually.  To make matters worse, health authorities say cancer care is no longer affordable in developed countries.

    Read the whole post »

  • Is Cancer Being Cured Right Before Our Eyes?

    Posted June 21, 2013: by Bill Sardi

    Cancer Center In Japan Reports Startling Remissions Using Vitamin & Immunotherapy Regimen

    In May of 2008 this health writer published an almost unbelievable report of four published studies of 4-7 year remissions from colon and breast cancer facilitated by weekly injection of an abundant sugar-like protein in human blood serum called Gc macrophage activating factor (Gc-MAF).  A year later I wrote a follow-up report showing lack of interest by the cancer care community in this remarkable development.

    Cancer cells secrete an enzyme called nagalase that completely blocks the conversion of Gc-protein to Gc-MAF which is needed to kill cancer cells via activation of white-blood cells known as macrophages.  Macrophages track down and engulf cancer cells.

    The startling aspect of these published reports is that the cancer community is ignoring them when there are simply no published studies showing long-term cures for any adult cancers.  For example, typical survival for lung and colon cancer is 2-years or less.

    Read the whole post »

  • Humans Can Mimic The Newly Discovered Cancer-Proof State Found In Naked Mole Rats

    Posted June 20, 2013: by Bill Sardi

    Now that we know why naked mole rats are impervious to cancer, the question arises – can we do this for humans?

    Naked mole rats (said to be naked because they are hairless) live about ten times longer than any other rodent.  But that is not all – they are cancer-proof animals!

    The discovery announced today was that a gooey sugar-like substance known as hyaluronan (hyaluronic acid) serves to protect cells in naked mole rats from becoming cancerous.

    While all animals produce hyaluronan, which is a water-holding gel in the body, the naked mole rat produces an unusually large (high molecular weight) form of this molecule.

    If knowledge is gained how to reproduce this cancer-repellant property in humans, the prospect of cancer-proof humans would be on the horizon.

    Read the whole post »

  • Hormone Replacement Therapy Risk Is Trivial.  But Why Take HRT or Tamoxifen When Flaxseed Works Better?

    Posted June 18, 2013: by Bill Sardi

    Defenders of hormone replacement therapy (HRT) now provide evidence that any alleged risks for cancer, stroke, blood clots or other maladies associated with HRT are not greater than those for other commonly-used drugs such as aspirin or statin cholesterol-lowering drugs.  Investigators claim risks for these infrequent maladies rise by less than 1 in 1000 HRT-treated women.

    What goes unsaid is that while sex hormone mildly increases the risk for breast cancer, dietary modifications can significantly decrease the risk while replacing the estrogen signal in the body.

    Researchers recently tested whether estrogen, tamoxifen (a drug anti-estrogen) or a flaxseed diet reduces the production of inflammatory factors called interleukin 1-a and 1-b associated with breast cancer.

    Read the whole post »

  • Follow Along As This Health Journalist Tracks Down A Breakthrough Drug That Alleges It Can Avert Double Mastectomies For Breast Cancer Patients.

    Posted June 10, 2013: by Bill Sardi

    Mindless medical reporting is rampant in the news media.  Biology-trained writers exercise no scrutiny over press releases issued by industry or public health authorities.  The public pays the price.  A recent example is a news report that says a new drug may avert the need for double mastectomies among breast cancer patients.

    In the wake of the disclosure by actress Angelina Jolie that she underwent double-sided mastectomy (removal of both breasts) due to her genetic propensity to develop breast cancer decades in her future, a pharmaceutical company has announced it is pursuing a “breakthrough” to “tackle a faulty gene” that causes this type of cancer.  The drug proposes to eliminate the need for double mastectomies.  Initial tests conducted among 70 patients produced “impressive responses” to the drug, called BMN673, a drug that targets the BRCA gene.

    BMN673 exhibits potent anti-tumor action by inhibition of an enzyme called PARP.

    Should women hold their breath now in eager anticipation of this drug?

    Read the whole post »

« Previous Entries Next Entries »